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Background: SLC25A33 and SLC25A36 are two 
human uncharacterized proteins encoded by the 
mitochondrial carrier SLC25 genes.  
Results: Recombinant SLC25A33 and SLC25A36 
transport cytosine, uracil and thymine 
(deoxy)nucleotides with different efficiency. 
Conclusions: SLC25A33 and SLC25A36 are 
mitochondrial transporters for pyrimidine 
(deoxy)nucleotides. 
Significance: SLC25A33 and SLC25A36 are 
essential for mitochondrial DNA and RNA 
metabolism; other two members of the SLC25 
superfamily responsible for 12 monogenic diseases 
were thoroughly characterized. 
 
ABSTRACT 
The human genome encodes 53 members 
of the solute carrier family 25 (SLC25), also 
called the mitochondrial carrier family, many of 
which have been shown to transport  inorganic 
anions, amino acids, carboxylates, nucleotides 
and coenzymes across the inner mitochondrial 
membrane, thereby connecting cytosolic and 
matrix functions. Here two members of this 
family, SLC25A33 and SLC25A36 have been 
thoroughly characterized biochemically. These 
proteins were overexpressed in bacteria and 
reconstituted in phospholipid vesicles. Their 
transport properties and kinetic parameters 
demonstrate that SLC25A33 transports uracil, 
thymine and cytosine (deoxy)nucleoside di- and 
tri-phosphates by an antiport mechanism and 
SLC25A36 cytosine and uracil (deoxy)nucleoside 
mono-, di- and tri-phosphates by uniport and 
antiport. Both carriers also transported guanine 
but not adenine (deoxy)nucleotides. Transport 
catalyzed by both carriers was saturable and 
inhibited by mercurial compounds and other 
inhibitors of mitochondrial carriers to various 
degrees. In confirmation of their identity, (i) 
SLC25A33 and SLC25A36 were found to be 
targeted to mitochondria and (ii) the phenotypes 
of Saccharomyces cerevisiae cells lacking RIM2, 
the gene encoding the well characterized yeast 
mitochondrial pyrimidine nucleotide carrier, 
were overcome by expressing SLC25A33 or 
SLC25A36 in these cells. The main physiological 
role of SLC25A33 and SLC25A36 is to 
import/export pyrimidine nucleotides into and 
from mitochondria, i. e. to accomplish transport 
steps essential for mitochondrial DNA and RNA 
synthesis and breakdown. 
 
The human genome harbours as many as 53 
SLC25 genes encoding a superfamily of transport 
proteins called solute carrier 25 (SLC25) family or 
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mitochondrial carrier family (MCF) (1, 2). The 
members of this family are characterized by three 
tandem repeated sequences of about 100 amino 
acids, each being folded into two transmembrane α-
helices and containing a distinct signature motif 
(PROSITE PS50920, PFAM PF00153, and 
IPR00193). In recent years many of these 
transporters have been investigated at the molecular 
and biochemical level. They transport inorganic 
anions, amino acids, carboxylic acids, nucleotides 
and coenzymes across the inner mitochondrial 
membrane and, in a few cases, across other 
membranes (1, 3-5). The importance of 
mitochondrial carriers is demonstrated by their wide 
distribution in all eukaryotes, their role in numerous 
metabolic pathways and cell functions, and the 
identification of several diseases caused by 
alterations of their genes (1, 2, 6-8). However, 
despite the research efforts of many laboratories, the 
transport properties and the substrate(s) transported 
by about twenty human mitochondrial carriers 
remain, as yet, unknown. 
The two human MCs SLC25A33 and 
SLC25A36, encoded by the SLC25A33 and 
SLC25A36 genes, respectively, are the close 
relatives of the Saccharomyces cerevisiae Rim2p. 
Deletion of RIM2 causes total loss of mtDNA and 
lack of growth on non-fermentative carbon sources 
(9). Furthermore, Rim2p has been demonstrated, by 
direct assays in reconstituted liposomes, to transport 
all pyrimidine ribo- and deoxyribo-nucleotides with 
similar efficiency as well as guanine ribo- and 
deoxyribo-nucleotides but not adenine nucleotides 
(10). Most information concerning SLC25A33, 
which was previously named PNC1, derives from 
studies in human cells in which PNC1 was silenced 
or overexpressed. PNC1 overexpression enhanced 
cell size, mitochondrial TTP levels and diminished 
ROS (reactive oxygen species), whereas its 
knockdown caused depletion of mtDNA, reduced 
oxidative phosphorylation, cell size and 
mitochondrial UTP levels, and increased ROS levels 
(11-13). Furthermore, analysis of nucleotide flow in 
cells with downregulation of PNC1 and treated with 
labeled uridine or thymidine revealed a slower 
mitochondrial uptake of uridine triphosphate and a 
slower release of thymine nucleotides to the 
cytoplasm (13). Finally, it has recently been found 
that Drosophila S2R+ cells, silenced for drim2 (the 
Drosophila melanogaster homolog of the S. 
cerevisiae Rim2p), contained markedly reduced 
pools of both purine and pyrymidine dNTPs in 
mitochondria, whereas cytosolic pools were 
unaffected (14).  
Until now the biochemical characterization 
of purified PNC1 has been addressed in a single 
publication in which the recombinant SLC25A33, 
reconstituted into liposomes, was shown to transport 
pyrimidine nucleoside triphosphates with preference 
for UTP (11). However, in this study only a limited 
number of potential substrates have been tested and, 
for example, it is unknown whether nucleoside 
mono- and di-phosphates are transported by 
SLC25A33.  
The high homology existing between 
SLC25A33 and SLC25A36 has suggested that these 
two members of the MCF might have similar 
functions (1, 2). However, the substrate(s) 
transported by SLC25A36 have not yet been 
discovered and its function is still completely 
elusive.  
This study reports the identification and 
functional characterization of SLC25A36 as well as 
a much more in depth characterization of 
SLC25A33 transport activity as compared to that 
reported by Floyd et al. (11). The SLC25A33 and 
SLC25A36 genes were overexpressed in E. coli, and 
the gene products were purified and reconstituted 
into liposomes. Recombinant SLC25A33 was 
shown to transport uracil, thymine and cytosine 
(deoxy)nucleoside di- and tri-phosphates and 
SLC25A36 cytosine and uracil (deoxy)nucleoside 
mono-, di- and tri-phosphates. Both SLC25A33- 
and SLC25A36-catalyzed transports were saturable 
and inhibited by mercurial compounds. The green 
fluorescent protein (GFP) fused to SLC25A36 was 
found to be targeted to mitochondria as previously 
shown for SLC25A33 (11). Furthermore, expression 
of SLC25A33 or SLC25A36 proved to restore the 
phenotypes of S. cerevisiae cells lacking RIM2 
encoding the yeast well characterized mitochondrial 
pyrimidine nucleotide carrier (10). As pyrimidine 
(deoxy)nucleotide transporters, SLC25A33 and 
SLC25A36 are essential for the synthesis and 
breakdown of mitochondrial DNA and RNA by 
providing the precursors and removing the products 
of these processes. 
 
EXPERIMENTAL PROCEDURES 
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Materials–Radioactive compounds were 
supplied from PerkinElmer Life Sciences. All 
(deoxy)nucleotides were obtained from Sigma.   
Sequence Search and Analysis–Protein and 
genomic data bases (www.ncbi.nlm.nih.gov) were 
screened with the protein sequence of SLC25A33 
(accession number NP_115691.1), and SLC25A36 
(accession number NP_001098117.1), using 
BLASTP and TBLASTN. The amino acid 
sequences were aligned with ClustalW (version 
1.8).  
Construction of Expression Plasmids–The 
coding sequences of SLC25A33 and SLC25A36 
(accession numbers NM_032315.2 and 
NM_001104647.1, respectively) were amplified by 
PCR from human testis and brain cDNA, 
respectively. The oligonucleotide primers were 
synthesized corresponding to the extremities of the 
coding sequences, with additional NdeI and HindIII 
(for SLC25A33) or BamHI and EcoRI (for 
SLC25A36) restriction sites as linkers. The 
amplified products were cloned into the pRUN 
(SLC25A33) and pMW (SLC25A36) vectors for 
expression in Escherichia coli.  
The RIM2-pRS42H plasmid was 
constructed by cloning a DNA fragment consisting 
of the 381 bp upstream the RIM2 open reading 
frame (ORF), the RIM2 ORF and the 352 bp 
downstream the RIM2 ORF (amplified from S. 
cerevisiae genomic DNA by PCR using primers 
with additional BamHI and SacI sites) into the 
episomal vector pRS42H. For the preparation of the 
SLC25A33-pRS42H and SLC25A36-pRS42SH 
plasmids, a chimera consisting of the 381 bp 
upstream the RIM2 ORF, the coding sequence of  
SLC25A33 or SLC25A36 with a 6 His-tag before the 
termination codon and the 352 bp downstream of 
the RIM2 ORF was constructed. Each of the three 
fragments was amplified using long primers 
consisting of the sequences corresponding to the 
extremities of the template to be amplified and an 
additional sequence corresponding to the extremity 
of the fragment to be linked with. After 
amplification and purification, the three fragments 
were mixed together and used in an overlapping 
PCR. First 5 cycles of PCR were run without 
primers to generate the complete overlapping 
template; then forward primers (first 25 nuceotides 
of the chimera with Hind III site) and reverse 
primers (last 25 nucleotides of the chimera with 
SacI site) were added and further 25 cycles of PCR 
were run. The two chimeras containing either the 
coding sequence of SLC25A33 or SLC25A36 were 
checked for correct overlapping and sequence 
errors; then they were digested with HindHI and 
SacI and cloned into the pRS42H plasmid. All the 
plasmids, prepared as above, were transformed into 
E. coli DH5α cells. Transformants were selected on 
2X YT plates containing ampicillin (100 µg/ml) and 
screened by direct colony PCR and by restriction 
digestion of purified plasmids. The sequences of the 
inserts were verified. 
 Bacterial expression and purification of 
recombinant SLC25A33 and SLC25A36–The 
expression of recombinant proteins was carried out 
at 37°C in E. coli strain BL21(DE3) (15, 16). 
Control cultures with the empty vector were 
processed in parallel. Inclusion bodies were purified 
on a sucrose density gradient (17) and washed at 
4°C, first with TE buffer (10 mM Tris/HCl, 1 mM 
EDTA, pH 7.0), then twice with a buffer containing 
3% (w/v) Triton X-114, 1 mM EDTA and 10 mM 
PIPES-NaOH pH 7.0, and lastly with TE buffer pH 
7.0. Finally, the recombinant SLC25A33 and 
SLC25A36 were solubilized in 1.2% (w/v) lauric 
acid and diluted 1:3 with 3% (w/v) Triton X-114, 10 
mM PIPES-NaOH pH 7.0 and 1 mM EDTA in the 
presence (SLC25A36) or absence (SLC25A33) of 
20 mM Na2SO4. Eventual small residues were 
removed by centrifugation (20800 x g for 20 min at 
4°C).  
Reconstitution of SLC25A33 and SLC25A36 
into liposomes–The recombinant proteins in lauric 
acid were reconstituted into liposomes by cyclic 
removal of the detergent with a hydrophobic column 
of Amberlite beads (Fluka), as previously described 
(18, 19) with some modifications. The composition 
of the initial mixture used for reconstitution was 50 
µl of purified protein (about 20 µg of SLC25A33 or 
30 µg of SLC25A36), 60 µl of 10% Triton X-114, 
100 µl of 10% phospholipids (L-α-
phosphatidylcholine from egg yolk, Sigma) in the 
form of sonicated liposomes, 10 mM substrate 
except where otherwise indicated, 0.6 mg 
(SLC25A33) or 1 mg (SLC25A36) cardiolipin, 10 
mM PIPES-NaOH, pH 7.0 (SLC25A33) or 5 mM 
MES-NaOH / 5 mM PIPES-NaOH, pH 6.25 
(SLC25A36) and water to a final volume of 700 µl. 
After vortexing, this mixture was recycled 13-fold 
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through an Amberlite column (3.2 x 0.5 cm) pre-
equilibrated with a buffer containing 10 mM PIPES-
NaOH at pH 7.0 (SLC25A33) or 5 mM MES-NaOH 
/ 5 mM PIPES-NaOH at pH 6.25 (SLC25A36) and 
the substrate at the same concentration as in the 
starting mixture.  
Transport measurements–External substrate 
was removed from proteoliposomes on Sephadex G-
75 columns pre-equilibrated with 50 mM NaCl and 
10 mM PIPES-NaOH at pH 7.0 for SLC25A33 
(buffer A) or 50 mM NaCl and 5 mM MES-NaOH / 
5 mM PIPES-NaOH at pH 6.25 for SLC25A36 
(buffer B). Transport at 25°C was started by adding 
the indicated labeled substrates to substrate-loaded 
proteoliposomes (exchange) or to empty 
proteoliposomes (uniport). In both cases, transport 
was terminated by addition of 30 mM pyridoxal 5'-
phosphate and 20 mM bathophenanthroline, which 
in combination and at high concentrations inhibit 
the activity of several mitochondrial carriers rapidly 
and completely (see, for example, Refs. 20-23). In 
controls, the inhibitors were added at the beginning 
together with the radioactive substrate. Finally, the 
external radioactivity was removed from each 
sample of proteoliposomes by a Sephadex G-75 
column pre-equilibrated with buffer A or buffer B 
for SLC25A33 and SLC25A36, respectively, and 
the entrapped radioactivity was measured. The 
experimental values were corrected by subtracting 
control values. The initial transport rate was 
calculated from the radioactivity taken up by 
proteoliposomes after 1.5 min (SLC25A33) or 3 
min (SLC25A36) (in the initial linear range of 
substrate uptake). For efflux measurements, 
proteoliposomes containing 2 mM substrate were 
labeled with 5 µM radioactive substrate by carrier-
mediated exchange equilibration (18, 24). After 40 
min, the external radioactivity was removed by 
passing the proteoliposomes through Sephadex G-
75 columns pre-equilibrated with buffer A or buffer 
B for SLC25A33 or SLC25A36, respectively. 
Efflux was started by adding unlabeled external 
substrate or buffer alone (buffer A for SLC25A33 
and buffer B for SLC25A36) to aliquots of 
proteoliposomes and terminated by adding the 
inhibitors indicated above. 
Subcellular localization–For the subcellular 
localization of SLC25A36 in Chinese hamster ovary 
(CHO) cells, these cells were co-transfected with 4 
µg of mtEBFP/pcDNAI (where EBFP stands for 
enhanced blue fluorescent protein) and 4 µg of a 
modified pcDNA3 plasmid containing the coding 
sequence of SLC25A36 fused with the enhanced 
green fluorescent protein (EGFP) sequence at the C-
terminus (25). EGFP and EBFP fluorescence were 
detected as described (25).   
Yeast strains, media and growth conditions–
The strains used in this study are all in W303 
genetic context (his3-11,15; ade2-1; leu2-3,112; 
ura3-1; trp1-1; can1-100). The wild-type W303 rho° 
haploid strain was produced as follows: cells were 
grown at a density of 1x106 cells/ml on YPD 
medium for 24 hours, then 0.05 M phosphate buffer 
pH 6.5 and 50 µg/ml etidium bromide were added to 
1 ml of culture. This culture was incubated at 28°C 
for 24 h. Then the cells were washed twice with 
H2O and plated on YPD medium. The lack of rho° 
cell growth was assessed on glycerol as carbon 
source and the absence of mtDNA by DAPI 
staining. RIM2Δ diploid strain 
(RIM2/RIM2::kanMX) was generated using the 
PCR-mediated gene disruption technique (26) by 
replacing one of the two wild-type RIM2 copies 
with the kanMX cassette in wild-type W303 diploid 
strain (EUROSCARF). This strain was sporulated to 
obtain the wild-type and the RIM2Δ haploid strains. 
To obtain RIM2Δ strain containing mtDNA, the 
RIM2Δ haploid strain was transformed with the 
RIM2-pRS42H, SLC25A33-pRS42H or SLC25A36-
pRS42H plasmid, and crossed with the wild-type 
haploid strain of opposite mating type to obtain the 
diploid strains. Cell crossing was generated by 
bringing near the cells on plate with the needle of 
the Singer micromanipulator. The generation of 
zygotes was usually produced in 2 hours. All the 
transformed RIM2Δ diploid strains were used for 
tetrad dissection in order to obtain transformed 
RIM2Δ haploid strains containing mtDNA (named 
RIM2Δ + RIM2, RIM2Δ + A33, RIM2Δ + A36).  
Wild-type, wild-type rho° and deletion 
strains were grown at 28°C in rich medium 
containing 1% bactopeptone and 1% yeast extract, 
supplemented with 2% glucose (YPD) or 3% 
glycerol (YPG). 2.2% bacto agar (Difco) was also 
present in solid media. In all cases the final pH was 
adjusted to 4.5. The pre-sporulation medium 
contained 1% yeast extract, 1% bactopeptone, 
0.17% yeast nitrogen base, 1% potassium acetate, 
0.5% ammonium sulphate and 0.05 M potassium 
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phthalate pH 5, and the sporulation medium 
contained 1% potassium acetate pH 7.6.  
Procedures for sporulation and dissection–
After 48 hours of growth on YPD plate at 28°C, 
diploid strains were inoculated in pre-sporulation 
medium; after 24 hours, cells were collected, 
washed two times in H2O and inoculated in the 
sporulation medium. To avoid plamid loss 
hygromycin (100 µg/ml) was added to the pre-
sporulation medium of the diploid strains containing 
the plasmid RIM2-pRS42H, SLC25A33-pRS42H or 
SLC25A36-pRS42H. The formation of tetrads was 
followed by microscopic observation and diploid 
strains were treated 18 minutes with cytohelicase 
(Sigma); the spores of asci were separated with the 
needle of the Singer micromanipulator. After three 
days, tetrad analysis was performed using marker 
selection: RIM2Δ spores were geneticin (G418) 
resistant; transformed RIM2Δ spores were 
hygromycin resistant.  
Microscopy–The microscope used was a 
Zeiss Axio Imager Z1 Fluorescence Microscope 
with AxioVision 4.8 Digital Image Processing 
System, and the objective len used was 63x Oil. The 
fluorescence was observed using filter sets for DAPI 
(365 nm excitation and 445/450 nm emission), 
DASPMI (550/25 nm excitation and 605/670 nm 
emission) and GFP (470/40 nm excitation and 
525/50 nm emission).  
Measurements of oxygen consumption–
Intact cell respiration was determined at 30°C using 
an Oxygraph-2 k system (Oroboros, Innsbruck) 
equipped with two chambers, and the data were 
analyzed using DatLab software (27). Exponentially 
growing cultures in YPD or YPG were harvested at 
an OD600 of 0.7 to 1, centrifuged at 3,000 x g for 5 
min at 4°C, and resuspended in YP at a density of 
approximately 5 OD600 units. 50 µl of this 
suspension correspondig to about 5 × 106 cells/ml 
were added to each chamber containing 2 ml of YP. 
The chambers were closed and respiration was 
recorded. The highest rate of respiration was 
determined by adding 0.5% ethanol and then 2.5-10 
µl of 2 mM carbonyl cyanide m-chloro- 
phenylhydrazone (CCCP) (Sigma). The addition of 
2 µM antimycin A (Sigma) accounted for non-
mitochondrial oxygen consumption. 
Other methods–Proteins were analyzed by 
SDS-PAGE and stained with Coomassie Blue dye. 
The identity of purified SLC25A33 and SLC25A36 
was assessed by matrix-assisted laser 
desorption/ionization-time-of-flight (MALDI-TOF) 
mass spectrometry of trypsin digests of the 
corresponding band excised from a Coomassie-
stained gel (28, 29). The amount of pure SLC25A33 
and SLC25A36 was estimated by laser densitometry 
of stained samples, using carbonic anhydrase as 
protein standard. To assay the protein incorporated 
into liposomes, the vesicles were passed through a 
Sephadex G-75 column, centrifuged at 300,000 x g 
for 30 min and delipidated with organic solvents as 
described in Capobianco et al. (30). Then, the SDS-
solubilized protein was determined by comparison 
with carbonic anhydrase in SDS gels. The share of 
incorporated SLC25A33 or SLC25A36 was about 
18% of the protein added to the reconstitution 
mixture. For fluorescence microscopy analyses cells 
were grown in YPD liquid medium at 28ºC; then 
exponential phase cells were fixed with 1% 
formaldehyde and treaded with 1 µg/ml DAPI (4',6-
diamidino-2-phenylindole, Sigma) for DAPI 
staining or treated with 1 mM DASPMI (2-(4-
(dimethylamino)styryl)-1-methylpyridinium iodide, 
Sigma) for DASPMI staining.  
 
RESULTS 
Subcellular localization of SLC25A36–
Since the presence of MCF proteins is by no means 
restricted to mitochondrial membranes (7, 31 and 
references therein) and the subcellular localization 
of SLC25A36 has not yet been determined, the 
intracellular localization of SLC25A36 was 
investigated. CHO cells were transfected with the 
pcDNA3-SLC25A36-EGFP plasmid, and images 
were acquired 40-45 hours after transfection. About 
35% of cells were transfected, and green 
fluorescence revealed typical mitochondrial 
localization of SLC25A36 (Fig. 1). Furthermore, the 
green fluorescence of the GFP-tagged protein 
completely overlapped with the blue fluorescence of 
a mitochondrially targeted BFP co-expressed in the 
same cells. Thus SLC25A36, which lacks a 
canonical mitocondrial targeting N-terminal 
extension, contains in its amino acid sequence the 
structural information for import into mitochondria 
in accordance with data available for other 
mitochondrial carriers (32, 33).   
Bacterial expression of SLC25A33 and 
SLC25A36–Reconstitution of recombinant proteins 
in liposomes is a method frequently used to identify 
 at U
N
IV
ERSITÀ STUDI LA SAPIENZA on November 23, 2018
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
  6 
transport properties of carrier proteins. Therefore, 
the open reading frames of SLC25A33 and 
SLC25A36 were expressed in E. coli BL21(DE3) 
cells (Fig. 2, lanes 4 and 7, respectively). The gene 
products accumulated as inclusion bodies and were 
purified by centrifugation and washing (Fig. 2, lanes 
5 and 8, respectively). The apparent molecular 
masses of the purified proteins were about 36.3 and 
36.8 kDa for SLC25A33 and SLC25A36, 
respectively, in good agreement with their 
respective molecular masses (calculated values with 
initiator methionine, 35.374 and 34.281 kDa, 
respectively). The identities of both recombinant 
proteins were confirmed by MALDI-TOF mass 
spectrometry and the yield of the purified proteins 
was approximately 40 mg per liter of culture for 
both SLC25A33 and SLC25A36. The recombinant 
proteins were not detected in bacteria harvested 
immediately before induction of expression (Fig. 2, 
lane 2 for SLC25A33), nor in cells harvested after 
induction but lacking the coding sequence in the 
expression vector (Fig. 2, lane 3 for SLC25A33 and 
lane 6 for SLC25A36).  
Functional characterization of SLC25A33 
and SLC25A36–In the search for potential substrates 
of SLC25A33 and SLC25A36, we based our choice 
on the fact that SLC25A33 was previously 
identified as a pyrimidine nucleotide carrier 
transporter of primarily UTP and both SLC25A33 
and SLC25A36 are related to Rim2p, which has 
been thoroughly characterized and shown to be the 
pyrimidine nucleotide transporter of mitochondria 
from S. cerevisiae (10). In homoexchange 
experiments (i.e., with the same substrate inside and 
outside), liposomes reconstituted with recombinant 
and purified SLC25A33 catalyzed active 
[3H]UTP/UTP and [3H]TTP/TTP exchanges and 
liposomes reconstituted with recombinant and 
purified SLC25A36 catalyzed active [3H]CTP/CTP 
and [3H]GTP/GTP exchanges (Fig. 3). These 
homoexchanges were completely inhibited by a 
mixture of pyridoxal 5’-phosphate and 
bathophenanthroline. In contrast, despite the long 
incubation period (i.e. 30 min) both SLC25A33- and 
SLC25A36-reconstituted liposomes did not catalyze 
homo-exchanges of NAD+, S-adenosyl methionine 
and arginine (Fig. 3). Importantly, no [3H]UTP/UTP 
and [3H]TTP/TTP exchange activities in liposomes 
reconstituted with SLC25A33 and no [3H]CTP/CTP 
and [3H]GTP/GTP exchange activities in liposomes 
reconstituted with SLC25A36 were detected when 
SLC25A33 or SLC25A36 had been inactivated by 
boiling before incorporation into liposomes, or 
when liposomes were reconstituted with sarkosyl-
solubilized protein from bacterial cells either 
lacking the expression vector or harvested 
immediately before induction of expression (results 
not shown). Furthermore, the above-mentioned 
homoexchanges were nil using pure liposomes, i.e. 
without incorporated protein (results not shown). 
The substrate specificities of reconstituted 
SLC25A33 and SLC25A36 were examined in–
depth by measuring the rates of [3H]UTP and 
[3H]CTP into SLC25A33- and SLC25A36-
reconstituted liposomes, respectively, that had been 
preloaded with various potential substrates (Fig. 4). 
The highest activities of SLC25A33-mediated 
[3H]UTP uptake into proteoliposomes were found 
with internal UTP, UDP, TTP and TDP (Fig. 4A). 
To a lesser extent [3H]UTP also exchanged with 
internal dUTP, CTP, CDP, dCTP, dCDP, GTP, 
GDP, dGTP, dGDP and ITP. In contrast, the uptake 
of [3H]UTP was negligible or very low in the 
absence of internal substrate (NaCl present, uniport) 
or in the presence of the following internal 
substrates: UMP, dUMP, TMP, CMP, dCMP, ATP, 
ADP, AMP, dATP, dADP, dAMP, GMP, dGMP, 
NAD+, FAD, coenzyme A, S-adenosyl methionine, 
phosphate, aspartate, lysine (Fig. 4A) and adenosine 
5’-phosphosulfate, cAMP, FMN, thiamine 
monophosphate, thiamine diphosphate, sulfate, 
succinate, malate, citrate, carnitine, glutamate, 
glutamine, arginine, cysteine and glutathione (not 
shown). The (deoxy)nucleoside mono-phosphates of 
the U, T and C bases were either not exchanged 
with external [3H]UTP or exchanged at a much 
lower rate than the corresponding (deoxy)nucleoside 
di- and tri-phosphates. The latter were transported at 
approximately the same rate by reconstituted 
SLC25A33. 
In liposomes reconstituted with SLC25A36 
( Fig. 4B) [3H]CTP exchanged efficiently with the 
(deoxy)nucleotides of the bases C, U, I and G. In 
contrast, the SLC25A36-mediated [3H]CTP uptake 
in the presence of internal thymine nucleotides and 
adenine (deoxy)nucleotides was not significantly 
higher than that found in the presence of NaCl. 
Similarly, the amount of radioactivity taken up in 
the presence of internal NAD+, FAD, coenzyme A, 
S-adenosyl methionine, phosphate, aspartate, lysine 
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(fig 4B) and adenosine 5’-phosphosulfate, cAMP, 
FMN, thiamine monophosphate, thiamine 
diphosphate, sulfate, succinate, malate, citrate, 
carnitine, glutamate, glutamine, arginine, cysteine 
and glutathione (not shown) was virtually the same 
as that taken up by uniport. At variance with the 
SLC25A33-mediated [3H]UTP transport (Fig. 4A), 
the nucleoside monophosphates of the C, U, I and G 
bases are clearly transported by reconstituted 
SLC25A36, although at a lower rate than the 
corresponding nucleoside tri- and di-phosphates. 
The deoxynucleotides of C, U and G were 
transported nearly at the same rate than the 
corresponding nucleotides.  
Effects of inhibitors on SLC25A33 and 
SLC25A36 activities–The effects of other 
mitochondrial carrier inhibitors on the activities of 
SLC25A33 and SLC25A36 were examined using 
[3H]UTP and [3H]CTP, respectively. Both the 
[3H]UTP/UTP and [3H]CTP/CTP exchange 
reactions catalyzed by reconstituted SLC25A33 and 
SLC25A36, respectively, were inhibited strongly by 
pyridoxal 5'-phosphate, bathophenanthroline, 
bromocresol purple, tannic acid and mercurials 
(HgCl2, mersalyl, p-hydroxymercuribenzoate) (Fig. 
5). The SLC25A33-mediated [3H]UTP exchange 
was inhibited partially by α-cyano-4-
hydroxycinnamate and N-ethylmaleimide. In 
contrast, the SLC25A36-mediated [3H]CTP 
exchange was inhibited markedly by α-cyano-4-
hydroxycinnamate and very poorly by N-
ethylmaleimide. Furthermore, little inhibition was 
observed with 1,2,3-benzenetricarboxylate, 
butylmalonate, phenylsuccinate, hemicholinium-3 
and quinine. Notably, bongkrekic acid inhibited the 
activities of SLC25A33 and SLC25A36 partially 
(36.7 and 40.5%, respectively), whereas 
carboxyatractyloside had a much lower effect at a 
concentration (10 µM) that completely inhibits the 
ADP/ATP carrier (34). The inhibitor sensitivity of 
SLC25A33 and SLC25A36, therefore, resembles 
that of yeast Rim2p but is not identical. 
Kinetic characteristics of recombinant 
SLC25A33 and SLC25A36–In Fig. 6A and 6B, the 
time-courses of 1 mM [3H]UTP or [3H]CTP uptake 
into liposomes reconstituted with SLC25A33 and 
SLC25A36, respectively, were compared either as 
uniport (in the absence of internal substrate) or as 
exchange (in the presence of 10 mM UTP or CTP, 
respectively). The exchange reactions catalyzed by 
both SLC25A33 and SLC25A36 followed first-
order kinetics, with isotopic equilibrium being 
approached exponentially. The rate constants and 
the initial rates of the exchanges deduced from the 
time-courses (18) were 0.04 and 0.02 min-1 and 91 
and 44 µmol / min x g protein for SLC25A33 and 
SLC25A36, respectively. In contrast, the uniport 
uptake of [3H]UTP by SLC25A33 was negligible 
and that of [3H]CTP by SLC25A36 was very low. 
The uniport mode of transport was further 
investigated by measuring the efflux of [3H]UTP or 
[3H]CTP from proteoliposomes preloaded with 
these compounds, because this experimental 
approach provides a more sensitive assay for 
unidirectional transport (18). As shown in Fig. 6C 
and 6D, in the absence of external substrate both the 
rate and extent of radioactive substrate efflux was 
very low from SLC25A33-reconstituted liposomes 
and substantial from SLC25A36-reconstituted 
liposomes. Of note, with both reconstituted carriers 
a rapid and extensive efflux of [3H]UTP or [3H]CTP 
occurred upon the addition of external UTP or CTP, 
respectively. Furthermore, both effluxes, i.e. with 
and without external substrate, were completely 
prevented if the inhibitors pyridoxal 5’-phosphate 
and bathophenanthroline were present from the 
beginning of the proteoliposome incubation (at time 
0). 
The kinetic constants of recombinant 
SLC25A33 and SLC25A36 were determined from 
the initial transport rate of homoexchanges at 
various external labeled substrate concentrations, in 
the presence of a fixed saturating internal substrate 
concentration of 10 mM (Table 1). The specific 
activity (Vmax) of SLC25A33 for the UTP/UTP 
exchange at 25°C was 2-fold greater than that of 
SLC25A36 for the CTP/CTP exchange, whereas the 
half-saturation constants (Km) of SLC25A33 for 
external UTP and of SLC25A36 for external CTP 
were nearly the same and similar to the 
physiological concentrations of UTP and CTP in 
human cells (35). Several external substrates were 
competitive inhibitors of SLC25A33 and 
SLC25A36, as they increased the apparent Km 
without changing the Vmax of the UTP/UTP and 
CTP/CTP exchange, respectively (not shown). The 
inhibitory constants (Ki) of these compounds for 
SLC25A33 were: 174 ± 20 µM (UTP), 195 ± 23 µM 
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(CTP), 318 ± 28 µM (GTP) and 333 ± 35 µM (ITP), 
and those for SLC25A36 were: 1.3 ± 0.2 mM 
(UTP), 224 ± 19 µM (CTP), 276 ± 26 µM (GTP) 
and 181 ± 25 µM (ITP). These results show that 
UTP and CTP are the best substrates of SLC25A33 
and SLC25A36, respectively. 
SLC25A33 and SLC25A36 genes are able to 
complement the absence of RIM2 in the S. 
cerevisiae RIM2 null mutant–To investigate whether 
the two human genes can replace the Rim2p 
function in vivo, the RIM2Δ haploid strain was 
transformed with the yeast plasmid pRS42H 
containing the SLC25A33 or SLC25A36 gene under 
the yeast RIM2 promoter (see Experimental 
procedures). The RIM2Δ haploid strain was unable 
to grow on non-fermentable carbon sources like 
glycerol (see next section), because this strain 
looses mtDNA at very high frequency, as visualised 
with DAPI staining (Fig. 7A and Ref. 9). As a 
consequence, in order to perform a gene 
complementation assay, it was necessary to 
reintroduce the mtDNA in the RIM2Δ strain 
transformed with SLC25A33 or SLC25A36. First we 
verified whether the RIM2Δ haploid strain 
transformed with the S. cerevisiae RIM2 gene could 
reintroduce the mtDNA. To this end this 
transformed strain was crossed with the wild type 
W303 haploid strain, so that, during meiosis, the 
mtDNA segregated in all four spores, including the 
two RIM2Δ haploid strains. After sporulation and 
tetrad analysis, the transformed RIM2Δ haploid 
strains (named RIM2Δ + RIM2) were selected; these 
strains were able to grow on glycerol (not shown). 
Furthermore, when stained with DAPI the RIM2Δ + 
RIM2 strain was found to contain mtDNA (Fig 7A), 
showing that RIM2 is essential to maintain mtDNA. 
To check whether stabilization of mtDNA in the 
RIM2Δ + RIM2 strain was due to the presence of 
RIM2 gene, a plasmid loss assay was performed and 
the resulting cells without plasmid were devoid of 
mtDNA (not shown).  
 Having verified that the presence of the 
RIM2 gene in RIM2Δ cells reintroduced the 
mtDNA, we applied the same procedure to 
investigate the effect of complementing RIM2Δ 
cells with SLC25A33 or SLC25A36. Fig. 7A shows 
that the S. cerevisiae RIM2Δ strains upon 
transformation with the SLC25A33 or SLC25A36 
gene, crossing with the wild-type strain, sporulation 
and tetrad dissection (named RIM2Δ + A33, RIM2Δ 
+ A36 strains, respectively) contained mtDNA, 
proving that both the two human genes are able to 
maintain mtDNA as the S.cerevisiae RIM2 gene 
does. The stabilization of mtDNA in RIM2Δ + A33 
and RIM2Δ + A36 was due to the presence of the 
human genes because (i) after the loss of plasmid 
containing SLC25A33 or SLC25A36, these strains 
were unable to grow on glycerol, and (ii) no 
mtDNA was observed when the RIM2Δ strain was 
transformed with the empty plasmid (data not 
shown). To verify whether the mitochondria were 
functional, all the strains under investigation were 
incubated with DASPMI, a vital dye which stains 
only the membranes of energized mitochondria with 
a membrane potential positive outside (36). As 
shown in Fig 7B, the mitochondrial membranes of 
the RIM2Δ strain as well as that of the wild type 
rho° strain were not stained by DASPMI; by 
contrast, the mitochondrial membranes of the 
RIM2Δ + RIM2, RIM2Δ + A33, RIM2Δ + A36 
strains were stained as the wild type strain, 
indicating that the mitochondria of the latter strains 
are functional. Furthermore, the mitochondrial 
morphology of the various S. cerevisiae strains was 
investigated by using mito-gfp, a mitochondria-
targeted green fluorescent protein (37). The RIM2Δ 
strain transformed with mito-gfp exhibited a 
fragmented mitochondrial morphology similar to 
that of wild type rho° cells (Fig 7C). In contrast, the 
RIM2Δ + RIM2, RIM2Δ + A33, RIM2Δ + A36 
strains transformed with mito-gfp displayed a 
typical tubular mitochondrial morphology, as the 
wild-type strain. These results demonstrate that the 
human genes SLC25A33 and SLC25A36 are able to 
complement the absence of RIM2 in S. cerevisiae 
cells restoring mtDNA, the mitochondrial 
membrane potential and the tubular mitochondrial 
morphology.  
 In another set of experiments the 
mitochondrial-dependent oxygen consumption of 
the wild-type, RIM2Δ, RIM2Δ + RIM2, RIM2Δ + 
A33 and RIM2Δ + A36 strains was measured in a 
high resolution oxygraph. With the exception of the 
RIM2Δ strain grown in YPD, all the other strains 
were grown in YPD (Fig. 8A) or YPG (Fig. 8B), 
and respiration was determined in YP medium. The 
oxygen consumption rate of the wild-type strain was 
0.57 nmol O2 x min -1 x 106 cells (Fig. 8A) and 1.61 
nmol O2 x min -1 x 106 cells (Fig. 8B),  values which 
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are close to those measured by other investigators 
under similar conditions (38,39). As shown in Fig. 
8A and 8B, independently from the fermentative or 
non-fermentative carbon source used for growth, the 
expression of RIM2 or each of the two human genes 
in RIM2Δ cells restored respiration to wild-type or 
higher levels. Virtually the same large differences 
between the wild-type, RIM2Δ, RIM2Δ + RIM2, 
RIM2Δ + A33 and RIM2Δ + A36 were found when 
measuring the highest rate of respiration in the 
presence of the uncoupler CCCP; indeed, the 
CCCP-stimulated respiration / basal respiration ratio 
was about 2.1 for all the strains grown both in YPD 
and YPG. 
SLC25A33 and SLC25A36 are able to 
rescue the lack of growth of the S. cerevisiae RIM2 
null mutant–The lack of growth of RIM2Δ cells on 
glycerol was largely restored by expressing 
SLC25A33, SLC25A36 or, as a control, RIM2 in 
mtDNA-containing RIM2Δ cells both in solid (Fig. 
9A) and liquid (Fig. 9B) YPG medium. In contrast, 
when the RIM2Δ cells were transformed with the 
empty vector, no growth restoration was observed 
(not shown). Similar results were obtained using 
ethanol and pyruvate as non-fermentative carbon 
sources, instead of glycerol, in solid and liquid 
media (data not shown). 
 
DISCUSSION 
 In humans several proteins have been 
identified at the molecular and biochemical level as 
mitochondrial carriers for adenine nucleotides (1, 2 
and references therein) but none of them transported 
pyrimidine ribo- or deoxy-nucleotides at any 
appreciable rate. These nucleotides are synthesized 
in the cytosol by the de novo pathway (absent in the 
mitochondria), and are required inside the 
mitochondrial matrix for DNA and RNA synthesis. 
Mitochondria contain the nucleotide salvage 
pathway which synthesizes nucleotides from the 
corresponding nucleosides that are transported into 
the organelles by the equilibrative nucleoside 
transporters hENT1 and hENT3 (40, 41). As the 
contribution of the salvage pathway to mtDNA 
synthesis is insufficient in quiescent cells and even 
more in cycling cells (42-44), pyrimidine 
nucleotides must be transported from the cytosol to 
the mitochondrial matrix. In the past a partial 
purification from human mitochondria of a carrier 
that displayed an efficient transport activity for 
dCTP has been achieved (45). Furthermore, in 
studies with isolated mitochondria evidence for a 
specific and saturable transporter for thymidine 
monophosphate has been provided (46). However, 
the molecular nature of these carriers has not been 
defined.  
 The results of this study including the 
transport properties and kinetic characteristics of 
recombinant SLC25A33 and SLC25A36, together 
with the localization to mitochondria of SLC25A36, 
presented here, and SLC25A33, reported previously 
(11), demonstrate that these proteins are 
mitochondrial transporters for pyrimidine ribo- and 
deoxy-nucleotides. These carriers share 59.8% 
identical amino acids. However, it is not possible to 
make reliable assumptions on the substrate 
specificity or on the transport modes on basis of the 
amino acid similarity. Therefore, we decided to 
analyze the biochemical properties of both proteins 
in a reconstituted system. Similar to other members 
of the MCF, SLC25A33 and SLC25A36 appear as 
inclusion bodies after recombinant synthesis in E. 
coli. Such inclusions, however, are advantageous 
since they allow the purification of the 
heterologously expressed carriers by centrifugation 
and washing. 
Our direct transport measurements show 
that SLC25A33 and SLC25A36 possess a similar 
substrate specificity. Indeed, both carriers transport 
pyrimidine nucleotides although with different 
efficiency. They also transport guanine and inosine 
nucleotides, but none of the many other compounds 
tested including adenine (deoxy)nucleotides and 
dinucleotides. However, SLC25A33 and SLC25A36 
differ in a number of transport properties. Unlike 
SLC25A36, SLC25A33 does not transport 
nucleoside monophophates. This carrier transports 
(deoxy)nucleoside di- and tri-phosphates at about 
the same rate with the following order of efficacy 
UXP > TXP > CXP. The best substrates of 
SLC25A36 are the cytosine (deoxy)nucleoside 
mono-, di- and tri-phosphates. In comparison with 
the cytosine (deoxy)nucleotides, the uracil 
nucleotides are transported by reconstituted 
SLC25A36 less efficiently and the thymine 
nucleotides virtually not at all. According to our 
kinetic data these large differences in the rate of 
pyrimidine nucleotide transport can be accounted 
for by the higher Km and lower Vmax values of 
SLC25A36 for uracil and thymine nucleotides than 
for cytosine nucleotides. The guanine 
(deoxy)nucleotides, which are also transported by 
both SLC25A33 and SLC25A36, have Km similar 
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to those of the respective best substrates but much 
lower Vmax values. Furthermore, in contrast to 
SLC25A33 and the great majority of mitochondrial 
carriers which are obligatory exchangers (1, 47), 
SLC25A36 catalyzes uniport besides exchange of 
substrates. In this respect, SLC25A36 resembles the 
carriers for phosphate, glutamate and 
carnitine/acylcarnitine, which are also capable of 
mediating uniport at a much lower rate than 
exchange (48-50).   
The substrate specificity of SLC25A33 and 
SLC25A36 is distinct from that of the about 30 
members of the MCF characterized until now. 
Furthermore, SLC25A33 and SLC25A36 do not 
exhibit significant sequence homology with any 
other MC greater than the homology exiting among 
the different members of the MCF. It is therefore 
likely that SLC25A33 and SLC25A36 are the only 
pyrimidine nucleotide carriers of the SLC25 family. 
As pyrimidine nucleotide carriers, 
SLC25A33 and SLC25A36 are essential for a 
number of major processes occurring in the 
mitochondria, i. e. the synthesis and breakdown of 
DNA and the various types of RNA including the 
RNA primers necessary for the initiation of DNA 
replication and repair. In these processes the 
pyrimidine (d)NTPs are the precursors of DNA and 
RNA synthesis and the pyrimidine (d)NMPs are the 
products of their breakdown. The biochemical 
properties of recombinant SLC25A33 [that does not 
transport (d)NMPs] indicate that the main function 
of this transporter is to catalyze the exchange of 
cytosolic pyrimidine (d)NTPs for intramitochondrial 
pyrimidine (d)NDPs. The latter can be produced 
inside the mitochondria by the intramitochondrial 
enzymes that convert pyrimidine (d)NMPs to the 
corresponding (d)NDPs (51,52). According to Floyd 
et al. (11) and Favre et al. (12) SLC25A33 is 
induced by the insulin-like growth factor signaling 
pathway to mTor and its expression is higher in 
transformed fibroblasts, cancer cell lines and 
primary prostate cancer than in normal tissues. It is 
therefore likely that SLC25A33 is operative mainly 
in cells which grow very rapidly. As regard to 
SLC25A36, on the basis of our transport 
measurements the primary physiological function of 
this carrier [that transports cytosine and uracil 
(deoxy)nucleoside mono-, di- and tri-phosphates] is 
probably to catalyze uptake of pyrimidine (d)NTPs 
into the mitochondrial matrix in exchange for 
internal pyrimidine (d)NMPs or, to a lesser extent, 
(d)NDPs. This exchange may play an important role 
in mitochondrial nucleic acid metabolism both in 
quiescent and cycling cells, in which the 
contribution of the salvage pathway is significant 
and minimal, respectively (42-44). It should be 
noted that the SLC25A36-mediated import of 
pyrimidine (d)NDPs in exchange for (d)NMPs 
should be relatively minor as compared to the 
uptake of (d)NTPs in exchange for (d)NMPs for 
thermodynamic reasons. Even if transported into 
mitochondria in exchange for (d)NMPs, (d)NDPs 
would recycle across the membrane exchanging 
with external (d)NTPs, thus accomplishing a net 
(d)NTPsout/(d)NMPsin exchange. Furthermore, 
SLC25A36 catalyzes an uniport transport mode 
besides exchange. The rate of uniport is much lower 
than that of the exchange. However, the uniport 
reaction may be necessary under certain conditions, 
for example during early development when 
mitochondrial biogenesis and the request for 
(d)NTPs is particularly high. 
Several important findings in vivo, i. e. the 
rescue in S. cerevisiae RIM2Δ cells of mtDNA, 
mitochondrial respiration, mitochondrial membrane 
potential and growth on glycerol and other 
respiratory substrates, strongly support SLC25A33 
and SLC25A36 controlling the uptake of pyrimidine 
(deoxy)nucleotides into mitochondria. Indeed, these 
RIM2Δ cell phenotypes can easily be accounted for 
by insufficient supply of pyrimidine 
(deoxy)nucleotides to the mitochondrial matrix, 
where they are indispensable for the synthesis of 
mtDNA, its transcription and replication. The 
altered mitochondrial morphology observed in 
RIM2Δ cells is similar to that exhibited by the wild-
type W303 rho° cells (fig.7), indicating that this 
unusual faulty mitochondrial structure is primarily 
caused by the loss of mtDNA (53). This phenotype 
of RIM2Δ cells is also restored by the SLC25A33 
and SLC25A36 genes suggesting a complete 
suppression of the RIM2Δ cells defects once the 
mitochondrial DNA is stabilized by the presence of 
these human proteins. It cannot be excluded, 
however, that additional changes in RIM2Δ cells 
may contribute to the observed alteration of the 
mitochondrial morphology. In this respect, it is 
worth mentioning that Rim2p has been reported to 
be needed in iron utilization in mitochondria, for 
example in Fe-S protein maturation and haem 
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synthesis (54), and be capable of transporting iron 
and other divalent metal ions into the mitochondria 
in co-transport with pyrimidine nucleotides (55). 
Future studies are warranted to investigate the 
effects of SLC25A33 and/or SLC25A36 knock-out 
in mice to provide further insight on the 
physiological roles of these mitochondrial 
transporters. It will also be of great interest to 
investigate whether antiviral and anticancer 
nucleoside analogs such as 2’,3’-dideoxycytidine, 
2’,3’-dideoxyinosine and 3’-azido-3’-
deoxythymidine, whose toxicity is due to 
mitochondrial function impairement, are transported 
by SLC25A33 and/or SLC25A36 from the cytosol, 
where they are phosphorylated, into the 
mitochondria where they inhibit the mtDNA 
polymerase γ. 
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FIGURE LEGENDS 
 
FIGURE 1. Subcellular localization of SLC25A36. CHO cells were transiently co-transfected with 
pcDNA3 vector carrying the DNA sequence coding SLC25A36 in frame with the GFP DNA sequence and 
pcDNAI plasmid carrying the DNA sequence of a mitochondrially targeted BFP (see experimental 
procedures). Images were acquired by a fluorescence microscope equipped with appropriate filters. 
SLC25A36-GFP, fluorescence of GFP fused to SLC25A36; mt-BFP, fluorescence of the mtBFP (here shown 
in red); overlay, merged image of mtBFP fluorescence with SLC25A36-GFP fluorescence. 
 
FIGURE 2. Expression in Escherichia coli and purification of SLC25A33 and SLC25A36. Proteins 
were separated by SDS-PAGE and stained with Coomassie blue dye. SLC25A33, lanes 1-5, SLC25A36, 
lanes 6-8; markers (bovine serum albumin, bovine carbonic anhydrase and cytochrome c) in the left column; 
lanes 1-4, 6 and 7, E. coli BL21(DE3) containing the expression vector, without (lanes 1, 3 and 6), with the 
coding sequence of SLC25A33 (lanes 2 and 4) and with the coding sequence of SLC25A36 (lane 7). Samples 
were taken immediately before induction (lanes 1 and 2) and 5 h later (lanes 3, 4, 6 and 7). The same number 
of bacteria was analyzed in each sample. Lanes 5 and 8, purified SLC25A33 (2 µg) and purified SLC25A36 
(4 µg) originated from bacteria shown in lanes 4 and 7, respectively. 
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FIGURE 3. Homo-exchange activities in liposomes reconstituted with SLC25A33 (A) or SLC25A36 
(B). Transport was initiated by adding the indicated radioactive substrate (final concentration, 0.2 mM) to 
proteoliposomes preloaded internally with the same substrate (concentration, 10 mM). Where indicated 
(UTP + i, TTP + i, CTP + i and GTP + i), the radioactive substrate was added together with 30 mM 
pyridoxal 5’-phosphate and 20 mM bathophenanthroline. The reaction was terminated after 30 min. The 
values are means ± S.D. of at least three independent experiments. Differences between the UTP/UTP and 
TTP/TTP (A) and the CTP/CTP and GTP/GTP (B) homoexchanges and the NAD+/NAD+, S-adenosyl 
methionine/S-adenosyl methionine and arginine/arginine homoexchanges were significant (p < 0.01, one 
way Anova and Bonferroni t-test). The difference between the UTP/UTP and the TTP/TTP homoexchanges 
in A and the difference between the CTP/CTP and the GTP/GTP homoexchanges in B were significant (p < 
0.05, one way Anova and Bonferroni t-test).  Abbreviations: SAM, S-adenosyl methionine. 
 
FIGURE 4. Dependence on internal substrate of the transport properties of liposomes reconstituted 
with recombinant SLC25A33 (A) and SLC25A36 (B). Proteoliposomes were preloaded internally with 
various substrates (each concentration 10 mM). Transport was started by adding 0.16 mM [3H]UTP or 0.2 
mM [3H]CTP to liposomes reconstituted with SLC25A33 or SLC25A36, respectively. The reaction time was 
1.5 min (SLC25A33) and 3 min (SLC25A36). The data are means ± S.D. of at least three independent 
experiments. In (A) differences between the activities of UTP uptake with internal UTP, UDP, dUTP, TTP, 
TDP, CTP, CDP, dCTP, dCDP, GTP, GDP, dGTP, dGDP and ITP and the activity with internal NaCl and no 
substrate were significant (p < 0.05, one way Anova and Bonferroni t-test). Differences between the 
activities of UTP uptake with internal substrate other than those mentioned above and the activity with 
internal NaCl were not significant (p > 0.05, one way Anova and Bonferroni t-test). In (B) differences 
between the activities of CTP uptake with internal UTP, UDP, UMP, dUTP, dUMP, CTP, CDP, CMP, 
dCTP, dCDP, dCMP, GTP, GDP, GMP, dGTP, dGDP, dGMP, ITP, IDP and IMP and the activity with 
internal NaCl were significant (p < 0.05, one way Anova and Bonferroni t-test). Differences between the 
activities of CTP uptake with internal substrate other than those mentioned above and the activity with 
internal NaCl were not significant (p > 0.05, one way Anova and Bonferroni t-test). Abbreviations: 
CoA, coenzyme A; SAM, S-adenosyl methionine; Pi, phosphate; Asp, aspartic acid; Lys, lysine. 
 
FIGURE 5. Effect of inhibitors on the [3H]UTP/UTP and [3H]CTP/CTP exchanges by  reconstituted 
SLC25A33 and SLC25A36, respectively. Transport was initiated by adding 0.16 mM [3H]UTP to 
SLC25A33-reconstituted liposomes preloaded internally with 10 mM UTP (black bars) or 0.2 mM [3H]CTP 
to SLC25A36-reconstituted liposomes preloaded with 10 mM CTP (hatched bars). The reaction time was 1.5 
min (SLC25A33) and 3 min (SLC25A36). Thiol reagents were added 2 min before the labeled substrate; the 
other inhibitors were added together with the labeled substrate. The final concentrations of the inhibitors 
were 20 mM (PLP, pyridoxal 5’-phosphate; BAT, bathophenanthroline), 0.2 mM (MER, mersalyl; p-HMB, 
p–hydroxymercuribenzoate; HgCl2), 2 mM (BMA, butylmalonate; BTA, 1,2,3-benzenetricarboxylate; 
PhSuc, phenylsuccinate), 1 mM (NEM, N-ethylmaleimide; CCN, α-cyano-4-hydroxycinnamate), 0.4 mM 
(HEM-3, hemicholinium-3; QUI, quinine), 0.3 mM (BrCP, bromocresol purple), 0.1% (TAN, tannic acid) 
and 10 µM (BKA, bongkrekic acid; CAT, carboxyatractyloside). The extents of inhibition (%) for each 
carrier from a representative experiment are reported. The data expressed as percentage of residual activity 
of SLC25A33-mediated [3H]UTP/UTP or SLC25A36-mediated [3H]CTP/CTP exchange are means ± S.E. of 
at least three independent experiments for each inhibitor and each carrier. The control values for uninhibited 
[3H]UTP/UTP and [3H]CTP/CTP exchanges were 45.9 ± 2.6 and 31.2 ± 1.5 µmol / min x g protein, 
respectively. 
 
FIGURE 6. Kinetics of [3H]UTP or [3H]CTP transport in liposomes reconstituted with SLC25A33 or 
SLC25A36, respectively. Liposomes were reconstituted with recombinant SLC25A33 (A and C) or 
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SLC25A36 (B and D). A and B, uptake of [3H]UTP and [3H]CTP. 1 mM [3H]UTP in A or 1 mM [3H]CTP in 
B was added to proteoliposomes containing 10 mM UTP in A or CTP in B (exchange, ) or 10 mM NaCl 
and no substrate (uniport, u). C and D, efflux of [3H]UTP and [3H]CTP. The internal substrate of 
proteoliposomes (2 mM UTP in C and 2 mM CTP in D) was labelled with [3H]UTP in C and [3H]CTP in D 
by carrier-mediated exchange equilibration. After removal of the external substrate by Sephadex G-75, the 
efflux of [3H]UTP (C) or [3H]CTP (D) was started by adding buffer alone (buffer A for SLC25A33 or buffer 
B for SLC25A36) (u) or in buffer A 5 mM UTP (), 30 mM pyridoxal 5'-phosphate and 20 mM 
bathophenanthroline (£), and 5 mM UTP, 30 mM pyridoxal 5'-phosphate and 20 mM bathophenanthroline 
(p) or in buffer B 5 mM CTP (¢),  30 mM pyridoxal 5'-phosphate and 20 mM bathophenanthroline (£) or 
5 mM CTP, 30 mM pyridoxal 5'-phosphate and 20 mM bathophenanthroline (p). The values are means of at 
least three independent experiments. 
 
FIGURE 7. The SLC25A33 and SLC25A36 human genes are able to complement the absence of RIM2 
in S. cerevisiae cells rescuing the mtDNA, the mitochondrial membrane potential and the tubular 
mitochondrial morphology. Wild-type W303, wild-type W303 rho°, RIM2Δ and RIM2Δ transformed with 
the RIM2-pRS42H, SLC25A33-pRS42H or SLC25A36-pRS42H plasmid (shown as WT, WT rho°, RIM2Δ, 
RIM2Δ + RIM2, RIM2Δ + A33 and RIM2Δ + A36, respectively) haploid strains were grown until 
exponential phase in liquid YPD medium at 28°C, and stained with: DAPI (A), DASPMI (B), mito-gfp (C). 
FIGURE 8. Mitochondrial respiration of wild-type W303, RIM2Δ, RIM2Δ + RIM2, RIM2Δ + A33, 
RIM2Δ + A36 strains. With the exception of the RIM2Δ cells, which were grown in YPD, the other cells 
were grown in YPD (A) or YPG (B), washed, resuspended in YP and tested for oxygen consumption. 
Respiration rates by the indicated cells were corrected for the oxygen consumption measured in the presence 
of antimycin A. Data represent mean ± S.D. of three independent experiments. In A and B, differences 
between the respiratory rates of wild-type, RIM2Δ + RIM2, RIM2Δ + A33 and RIM2Δ + A36 cells and the 
respiratory rate of RIM2Δ cells were significant (p < 0.01, one-way Anova and Bonferroni t-test). In A the 
differences between the respiratory rates of RIM2Δ + RIM2, RIM2Δ + A33 and RIM2Δ + A36 cells and the 
respiratory rate of wild-type cells were not significant (p > 0.05, one-way Anova and Bonferroni t-test). In B 
the differences between the respiratory rates of RIM2Δ + A33 and RIM2Δ + A36 cells and the respiratory 
rate of wild-type cells were significant (p < 0.05, one-way Anova and Bonferroni t-test), whereas the 
difference between the respiratory rate of RIM2Δ + RIM2 cells and that of wild-type cells was not significant 
(p > 0.05, one-way Anova and Bonferroni t-test). 
 
FIGURE 9. Effect of complementing S. cerevisiae RIM2Δ cells with human SLC25A33 or SLC25A36 on 
growth. Wild-type W303, RIM2Δ and RIM2Δ transformed with the RIM2-pRS42H, SLC25A33-pRS42H or 
SLC25A36-pRS42H plasmid (shown as WT, RIM2Δ, RIM2Δ + RIM2, RIM2Δ + A33, RIM2Δ + A36, 
respectively) haploid strains were spotted on solid YPG medium for 48 hours at 30°C as 4-fold serial 
dilution (A) or were inoculated in liquid YPG medium at 30°C (B). The values of optical density at 600 nm 
refer to cell cultures after the indicated times of growth. The values are means of three independent 
experiments. (), WT; (), RIM2Δ; (¿), RIM2Δ + RIM2; (£), RIM2Δ + A33; and (¢), RIM2Δ + A36 
strains.  
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Table 1. Kinetic parameters of recombinant SLC25A33 and SLC25A36. Km and Vmax were calculated 
from double-reciprocal plots of the rates of [3H]UTP, [3H]CTP, [3H]TTP, or [3H]GTP uptake at various 
concentrations into proteoliposomes containing the same substrates (concentration, 10 mM). The data 
represent the means ± S.D. of at least four independent experiments. 
 
 SLC25A33  SLC25A36 
homoexchanges Km Vmax  Km Vmax 
 mM µmol / min x g protein  mM µmol / min x g protein 
[3H]UTP/UTP  0.16 ± 0.01        98.5 ± 10.2    1.19 ± 0.15        30.7 ± 4.4 
[3H]CTP/CTP  0.18 ± 0.02        22.5 ± 3.8    0.21 ± 0.02        51.2 ± 5.7 
[3H]TTP/TTP  0.08 ± 0.01        50.8 ± 6.1  >2.5     < 8 
[3H]GTP/GTP  0.30 ± 0.02        15.7 ± 2.4    0.23 ± 0.04        23.6 ± 2.9 
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